Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration

Trial Profile

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Ertapenem (Primary)
  • Indications Bacterial infections; Benign prostatic hyperplasia; Gynaecological infections; Skin and soft tissue infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Acronyms ERTAPRO
  • Most Recent Events

    • 29 Jan 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 08 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.
    • 08 Apr 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top